The thoughtful integration of artificial intelligence (AI) with multiomics is reshaping the diagnostic and therapeutic landscape in localized non–small cell lung cancer (NSCLC). Although the hype ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback